Novavax Inc

NVAXNASDAQ · USD
10.11USD0.00 (+1.10%)
269

Novavax Inc (NVAX) Option Chain

As of September 18, 2026, Novavax Inc is trading at $10.11, a +1.10% change from the previous close. The nearest expiration is Sep 25, 2026. Implied volatility is 69.7%. IV Rank is 17%.

Read more

Tracking the NVAX option chain helps you see every strike and expiry on Novavax Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Novavax Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NVAX options activity at a glance. Use our scanner to monitor the NVAX option chain in real time and filter for the NVAX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NVAX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the NVAX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where NVAX stock options are being actively traded and where they are not.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics.

It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Novavax Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen NVAX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of NVAX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile26.59% Subdued
  • Market cap (M$)1,668
  • 52 weeks high-15.54%
  • 52 weeks low63.06%
  • Analyst recommendationBuy
    2.29
  • Target price$14.71
    45.50% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-1.52
  • EPS growth next 5 years

As of September 18, 2026

2026-09-25
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
10.74235155-0.031.110.941.219.00-10.980.030.080.000.069785489.26
25.9176260.770.610.632.139.50-6.030.040.180.000.115627074.09
46.723405150.280.110.350.4210.00-1.090.530.000.5315715153.28
67.511,9885670.210.000.180.2410.50+3.860.531.020.390.38112932.49
83.291,439110.100.000.080.1111.00+8.800.851.600.890.330116.71

As of September 18, 2026

Scan the full option chain in one place

Browse the full NVAX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial